Concurrent Investment Advisors LLC Sells 3,835 Shares of Marsh & McLennan Companies, Inc. $MRSH

Concurrent Investment Advisors LLC decreased its holdings in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) by 17.9% in the 2nd quarter, Holdings Channel.com reports. The firm owned 17,547 shares of the financial services provider’s stock after selling 3,835 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Marsh & McLennan Companies were worth $2,925,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently added to or reduced their stakes in MRSH. BlackRock Inc. bought a new stake in shares of Marsh & McLennan Companies in the second quarter valued at approximately $6,583,806,000. State Street Corp bought a new position in Marsh & McLennan Companies during the fourth quarter worth $4,057,682,000. Capital International Investors acquired a new position in Marsh & McLennan Companies during the 4th quarter valued at $3,482,557,000. Capital World Investors bought a new stake in Marsh & McLennan Companies in the 4th quarter valued at $3,140,284,000. Finally, Wellington Management Group LLP acquired a new stake in Marsh & McLennan Companies in the 4th quarter worth $2,967,927,000. 87.99% of the stock is owned by institutional investors.

Insider Activity at Marsh & McLennan Companies

In other Marsh & McLennan Companies news, Director Lloyd Yates sold 12,000 shares of the company’s stock in a transaction on Thursday, July 23rd. The stock was sold at an average price of $175.65, for a total value of $2,107,800.00. Following the sale, the director directly owned 12,001 shares in the company, valued at $2,107,975.65. This represents a 50.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Martin South sold 7,100 shares of the stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total value of $1,348,929.00. Following the transaction, the insider owned 16,632 shares of the company’s stock, valued at $3,159,913.68. This represents a 29.92% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 19,813 shares of company stock valued at $3,597,903 in the last 90 days. 0.38% of the stock is owned by corporate insiders.

Marsh & McLennan Companies Stock Performance

NYSE:MRSH opened at $185.80 on Tuesday. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 1.22. The stock’s 50-day simple moving average is $185.49. Marsh & McLennan Companies, Inc. has a 52 week low of $156.60 and a 52 week high of $207.82. The company has a market cap of $88.67 billion, a P/E ratio of 22.71, a price-to-earnings-growth ratio of 2.58 and a beta of 0.58.

Marsh & McLennan Companies (NYSE:MRSH) last posted its quarterly earnings results on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.89 by $0.07. The firm had revenue of $7.28 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. Marsh & McLennan Companies’s revenue was up 6.2% compared to the same quarter last year. Sell-side analysts forecast that Marsh & McLennan Companies, Inc. will post 10.44 EPS for the current year.

Marsh & McLennan Companies Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Thursday, July 23rd were issued a $0.99 dividend. This represents a $3.96 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend was Thursday, July 23rd. This is a boost from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. Marsh & McLennan Companies’s payout ratio is currently 48.41%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on MRSH. Piper Sandler cut their price objective on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research report on Tuesday, May 26th. JPMorgan Chase & Co. boosted their price target on Marsh & McLennan Companies from $206.00 to $212.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. Morgan Stanley upped their price target on Marsh & McLennan Companies from $180.00 to $200.00 and gave the company an “equal weight” rating in a report on Wednesday, August 19th. Citigroup downgraded Marsh & McLennan Companies from a “buy” rating to a “neutral” rating and set a $200.00 price objective for the company. in a research report on Wednesday, July 22nd. Finally, Cantor Fitzgerald boosted their price objective on Marsh & McLennan Companies from $210.00 to $218.00 and gave the company an “overweight” rating in a research report on Thursday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $203.50.

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.